top of page
Our Portfolio Companies
Single-cell spatial profiling technology​
(Acquired by Takara)
Next-generation digital counting platform
Targeted therapies tackling drug resistance
Genetic medicine for autoimmune diseases
Precision oncology with breakthrough therapy
bottom of page